Emmes Acquires Institut Dr. Schauerte

Emmes, a global, full-service Clinical Research Organization dedicated to supporting the advancement of public health and biopharmaceutical innovation, has announced that it has acquired Institut Dr. Schauerte, a CRO headquartered in Munich, Germany. Founded in 1990, Institut Dr. Schauerte is a full-service, technology-oriented CRO that specializes in late-phase, non-interventional, and post-market clinical follow-up studies. It has conducted more than 400 studies across a range of therapeutic areas.

Dr. Schauerte and Institut Dr. Schauerte's leaders and staff will continue in their current roles.

Emmes Acquires Institut Dr. Schauerte, Entering Real World Evidence Market